ESOMEPRAZOL IN TREATMENT OF GASTROESOPHAGIAL REFLUX DISEASE IN CHILDREN AND ADOLESCENTS

The results of trials of activity of esomeprazol in children with gastroesophagial reflux disease (gerd) are presented in this article. It was marked that esomeprazol (Nexium) can be used in children of 1–11 years (10 or 20 mg daily) and 12–17 years (20 or 40 mg daily) with gerd according to modern...

Ausführliche Beschreibung

Bibliographische Detailangaben
1. Verfasser: R.T. Saygitov
Format: Artikel
Sprache:English
Veröffentlicht: "Paediatrician" Publishers LLC 2008-08-01
Schriftenreihe:Вопросы современной педиатрии
Online Zugang:https://vsp.spr-journal.ru/jour/article/view/1441

Ähnliche Einträge